Aquestive Therapeutics (AQST) Asset Utilization Ratio (2018 - 2026)
Aquestive Therapeutics' Asset Utilization Ratio came in at 0.40 for Q2 2026, down 12.1% from 0.45 a year earlier but up 18.7% from the prior quarter.
Powered by 
Analysis
Aquestive Therapeutics (AQST) Asset Utilization Ratio (2018 - 2026) Analysis & Trends
For FY2025, Aquestive Therapeutics' Asset Utilization Ratio was 0.34, down 53.1% from FY2024.
- Going back by year, Asset Utilization Ratio was 0.72 in FY2024 (-18.0%), 0.88 in FY2023 (+10.3%), 0.80 in FY2022 (-1.6%) and 0.81 in FY2021 (+25.5%).
- The five-year range for quarterly Asset Utilization Ratio is 0.27 (Q4 2025) to 0.89 (Q3 2022).
- Year-over-year, Asset Utilization Ratio has declined for 14 consecutive quarters, with an average decline of 27.0% over the last eight quarters.
- The fastest year-over-year change in Asset Utilization Ratio over five years came in Q2 2022 (growth of 36.0%), and the weakest in Q4 2025 (a decline of 49.5%).
- Business Quant data shows AQST's Asset Utilization Ratio at 0.33 (Q1 2026), 0.27 (Q4 2025) and 0.34 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 0.47 |
| 10 | Aquestive Therapeutics | 581.12 Mn | 121.66 Mn | 9.80 Mn | 0.40 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.40 |
| Mar 31, 2026 | 0.33 |
| Dec 31, 2025 | 0.27 |
| Sep 30, 2025 | 0.34 |
| Jun 30, 2025 | 0.45 |
| Mar 31, 2025 | 0.53 |
| Dec 31, 2024 | 0.54 |
| Sep 30, 2024 | 0.52 |
| Jun 30, 2024 | 0.47 |
| Mar 31, 2024 | 0.55 |
| Dec 31, 2023 | 0.87 |
| Sep 30, 2023 | 0.83 |
| Jun 30, 2023 | 0.79 |
| Mar 31, 2023 | 0.79 |
| Dec 31, 2022 | 0.88 |
| Sep 30, 2022 | 0.89 |
| Jun 30, 2022 | 0.88 |
| Mar 31, 2022 | 0.88 |
| Dec 31, 2021 | 0.80 |
| Sep 30, 2021 | 0.71 |
API Access
Aquestive Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();